Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin

被引:27
作者
Kuehne, Sarah A. [1 ,2 ,3 ,4 ]
Dempster, Andrew W. [1 ]
Collery, Mark M. [1 ,6 ]
Joshi, Nimitray [1 ]
Jowett, Jamie [1 ]
Kelly, Michelle L. [1 ]
Cave, Rory [1 ]
Longshaw, Chris M. [5 ,7 ]
Minton, Nigel P. [1 ,2 ,3 ]
机构
[1] Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Clostridia Res Grp, Nottingham NG7 2RD, England
[2] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr BRC, Gastrointestinal & Liver Disorders Theme, Nottingham, England
[3] Univ Nottingham, Nottingham, England
[4] Univ Birmingham, Inst Clin Sci, Sch Dent, Coll Med & Dent Sci, Birmingham, W Midlands, England
[5] Astellas Pharma Europe Ltd, Chertsey, England
[6] Micropathology Ltd, Univ Warwick Sci Pk, Coventry, W Midlands, England
[7] Basilea Pharmaceut Ltd, Guildford, Surrey, England
关键词
RIFAMPIN RESISTANCE; TOXIN-B;
D O I
10.1093/jac/dkx486
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To establish the role of specific, non-synonymous SNPs in the RNA polymerase beta subunit (rpoB) gene in reducing the susceptibility of Clostridium difficile to fidaxomicin and to explore the potential in vivo significance of rpoB mutant strains. Methods: Allelic exchange was used to introduce three different SNPs into the rpoB gene of an erythromycin-resistant derivative (CRG20291) of C. difficile R20291. The genome sequences of the created mutants were determined and each mutant analysed with respect to growth and sporulation rates, toxin A/B production and cytotoxicity against Vero cells, and in competition assays. Their comparative virulence and colonization ability was also assessed in a hamster infection model. Results: The MIC of fidaxomicin displayed by three mutants CRG20291-TA, CRG20291-TG and CRG20291-GT was substantially increased (>32, 8 and 2 mg/L, respectively) relative to that of the parent strain (0.25 mg/L). Genome sequencing established that the intended mutagenic substitutions in rpoB were the only changes present. Relative to CRG20291, all mutants had attenuated growth, were outcompeted by the parental strain, had lower sporulation and toxin A/B production capacities, and displayed diminished cytotoxicity. In a hamster model, virulence of all three mutants was significantly reduced compared with the progenitor strain, whereas the degree of caecum colonization was unaltered. Conclusions: Our study demonstrates that particular SNPs in rpoB lead to reduced fidaxomicin susceptibility. These mutations were associated with a fitness cost in vitro and reduced virulence in vivo.
引用
收藏
页码:973 / 980
页数:8
相关论文
共 33 条
[1]  
[Anonymous], 2013, ANTIBIOTIC RESISTANC
[2]   Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis [J].
Artsimovitch, Irina ;
Seddon, Jaime ;
Sears, Pamela .
CLINICAL INFECTIOUS DISEASES, 2012, 55 :S127-S131
[3]   Estimation of temperature dependent growth rate and lag time of Listeria monocytogenes by optical density measurements [J].
Augustin, JC ;
Rosso, L ;
Carlier, V .
JOURNAL OF MICROBIOLOGICAL METHODS, 1999, 38 (1-2) :137-146
[4]   Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027 [J].
Burns, David A. ;
Heeg, Daniela ;
Cartman, Stephen T. ;
Minton, Nigel P. .
PLOS ONE, 2011, 6 (09)
[5]   Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection [J].
Citron, D. M. ;
Babakhani, F. ;
Goldstein, E. J. C. ;
Nagaro, K. ;
Sambol, S. ;
Sears, P. ;
Shue, Y. -K. ;
Gerding, D. N. .
ANAEROBE, 2009, 15 (06) :234-236
[6]  
Clinical and Laboratory Standards Institute, 2012, M11A8 CLSI, V8th
[7]   Best Strategies in Recurrent or Persistent Clostridium difficile Infection [J].
Cocanour, Christine S. .
SURGICAL INFECTIONS, 2011, 12 (03) :235-239
[8]   Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation [J].
Colicchio, Roberta ;
Pagliuca, Chiara ;
Pastore, Gabiria ;
Cicatiello, Annunziata Gaetana ;
Pagliarulo, Caterina ;
Tala, Adelfia ;
Scaglione, Elena ;
Sammartino, Jose Camilla ;
Bucci, Cecilia ;
Alifano, Pietro ;
Salvatore, Paola .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) :7637-7649
[9]   Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin [J].
Comely, Oliver A. ;
Miller, Mark A. ;
Louie, Thomas J. ;
Crook, Derrick W. ;
Gorbach, Sherwood L. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 :S154-S161
[10]   Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden [J].
Dang, Uyen T. ;
Zamora, Idalia ;
Hevener, Kirk E. ;
Adhikari, Sudip ;
Wu, Xiaoqian ;
Hurdle, Julian G. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) :5604-5607